Gomis R - Search Results

1

Effects of a short prednisone regime at clinical onset of type 1 diabetes.

Goday A, Pujol-Borrell R, Fernandez J, Casamitjana R, Rios M, Vilardell E, Gomis R. Goday A, et al. Among authors: gomis r. Diabetes Res Clin Pract. 1993 Apr;20(1):39-46. doi: 10.1016/0168-8227(93)90020-6. Diabetes Res Clin Pract. 1993. PMID: 8344127 Clinical Trial.

2

Insulin lispro is as effective as regular insulin in optimising metabolic control and preserving beta-cell function at onset of type 1 diabetes mellitus.

Recasens M, Aguilera E, Morínigo R, Casamitjana R, Nicoletti F, Gomis R, Conget I. Recasens M, et al. Among authors: gomis r. Diabetes Res Clin Pract. 2003 Jun;60(3):153-9. doi: 10.1016/s0168-8227(03)00036-6. Diabetes Res Clin Pract. 2003. PMID: 12757987 Clinical Trial.

3

Natural history of islet cell antibodies during the clinical period of type 1 diabetes. High titres at diagnosis are associated with longer persistence.

Goday A, Fernandez J, Gonzalez-Clemente JM, Ferrer J, Usach E, Gomis R, Vilardell E. Goday A, et al. Among authors: gomis r. Diabetes Res. 1991 Aug;17(4):169-74. Diabetes Res. 1991. PMID: 1823637

4

HLA antigens in Spanish type 1 diabetic population. Correlations with clinical, biological and autoimmune markers.

Goday A, Motaña E, Ercilla G, Fernandez J, Gomis R, Vilardell E. Goday A, et al. Among authors: gomis r. Acta Diabetol Lat. 1990 Jul-Sep;27(3):215-22. doi: 10.1007/BF02581333. Acta Diabetol Lat. 1990. PMID: 2075784

5

Islet-cell antibodies: markers of a more severe insulin-dependent diabetes mellitus?

Montaña E, Goday A, Rosel P, Casamitjana R, Soler J, Gomis R. Montaña E, et al. Among authors: gomis r. Diabetes Res. 1989 Aug;11(4):167-71. Diabetes Res. 1989. PMID: 2625032

6

Suppression by insulin treatment of glucose-induced inhibition of insulin release in non-insulin-dependent diabetics.

Gomis R, Novials A, Coves MJ, Casamitjana R, Malaisse WJ. Gomis R, et al. Diabetes Res Clin Pract. 1989 Apr 1;6(3):191-8. doi: 10.1016/0168-8227(89)90029-6. Diabetes Res Clin Pract. 1989. PMID: 2656169

7

Correlation between residual beta-cell function and islet cell antibodies in newly diagnosed type I diabetes. Follow-up study.

Peig M, Gomis R, Ercilla G, Casamitjana R, Bottazzo GF, Pujol-Borrell R. Peig M, et al. Among authors: gomis r. Diabetes. 1989 Nov;38(11):1396-401. doi: 10.2337/diab.38.11.1396. Diabetes. 1989. PMID: 2695374

8

The effect of hypoglycemic sulfonylureas on human red blood cell transglutaminase activity.

Gomis R, Casanovas A, Casamitjana R, Sarto A, Arroyo J, Coves MJ, Rivera F, Vilardell E. Gomis R, et al. Diabetes Res Clin Pract. 1988 May 19;5(1):31-6. doi: 10.1016/s0168-8227(88)80075-5. Diabetes Res Clin Pract. 1988. PMID: 2900125

9

Presence of insulin autoantibodies at clinical diagnosis of diabetes mellitus type I predicts loss of beta cell function.

Gomis R, Recasesns A, Peig M, Casamitjana R, Pujol-Borrell R, Rivera F, Vilardell E. Gomis R, et al. Autoimmunity. 1988;1(4):299-305. doi: 10.3109/08916938809010683. Autoimmunity. 1988. PMID: 2979623

10

Microalbuminuria development in short-term IDDM.

González-Clemente JM, Esmatjes E, Navarro P, Ercilla G, Casamitjana R, Rios M, Levy I, Gomis R, Vilardell E. González-Clemente JM, et al. Among authors: gomis r. Diabetes Res Clin Pract. 1994 May;24(1):15-23. doi: 10.1016/0168-8227(94)90081-7. Diabetes Res Clin Pract. 1994. PMID: 7924882

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

470 results

Search Page